About Pilot gene technology
Pilot gene technology is a company based in Hangzhou (China) founded in 2017. Pilot gene technology has raised $18.51 million across 1 funding round from investors including Share Capital. Pilot gene technology offers products and services including Digital PCR System and PCR Detection Kits.
- Headquarter Hangzhou, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 领航基因科技（杭州）有限公司
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.51 M (USD)
in 1 rounds
-
Latest Funding Round
$18.51 M (USD), Series A
Jul 19, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pilot gene technology
Pilot gene technology offers a comprehensive portfolio of products and services, including Digital PCR System and PCR Detection Kits.
Digital PCR systems are utilized for pathogen detection in clinical environments, where they are applied to analyze samples for infections
PCR detection kits are employed for rapid testing of conditions like bloodstream infections, where they are integrated into automated systems for efficient results
Funding Insights of Pilot gene technology
Pilot gene technology has successfully raised a total of $18.51M through 1 strategic funding round. The most recent funding activity was a Series A round of $18.51 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pilot gene technology
Pilot gene technology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Share Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital firm based in Shenzhen, China, is operated.
|
Locked | Locked | Locked |
Investor details for Pilot gene technology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pilot gene technology
Investment portfolio details for Pilot gene technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pilot gene technology
Detailed financials for Pilot gene technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pilot Gene Technology Comparisons
Peer comparison for Pilot gene technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pilot gene technology
Detailed competitors of Pilot gene technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pilot Gene Technology
Complete news archive for Pilot gene technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pilot gene technology
Pilot gene technology was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Pilot gene technology is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Pilot gene technology is a funded company, having raised a total of $18.51M across 1 funding round to date.
Pilot Gene Technology was established in 2017 and is based in Hangzhou, China. Focus is placed on research and development, production, and supply within the biotechnology sector, specifically digital PCR technologies. Operations involve creating tools for precise genetic quantification and analysis. Products are distributed to support applications in molecular diagnostics and research, with activities centered in the Asia-Pacific region.
Pilot gene technology offers Digital PCR System and PCR Detection Kits.
Pilot gene technology has 1 investor. Key investors include Share Capital.